Literature DB >> 1939593

Vancomycin susceptibility and identification of motile enterococci.

S Vincent1, R G Knight, M Green, D F Sahm, D M Shlaes.   

Abstract

Thirty-seven clinical isolates of Enterococcus gallinarum and Enterococcus casseliflavus and three type or reference strains of the species were studied with respect to vancomycin susceptibility and key identification characteristics. With the exception of one clinical isolate of E. casseliflavus (MIC, 4 micrograms/ml), MICs of vancomycin were 8 to 32 micrograms/ml. The type strain of E. gallinarum, NCDO 2313, and five of the clinical isolates had similar penicillin-binding protein profiles and shared 90 to 100% DNA homology. Two isolates, identified as E. gallinarum by conventional tests, were shown to be non-pigment-producing E. casseliflavus on the basis of penicillin-binding protein profile and DNA homology. The type and reference strains of E. casseliflavus, ATCC 25788 and ATCC 25789, were nonmotile in our experiments. However, both shared 65 to 100% DNA homology with each other and with five clinical isolates of E. casseliflavus. These data suggest that the MICs of vancomycin observed for strains of E. gallinarum and E. casseliflavus are higher than those usually associated with other enterococci and may be a common property of these species. Additionally, pigment production and motility may occasionally be misleading criteria for definitive identification of these organisms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939593      PMCID: PMC270325          DOI: 10.1128/jcm.29.10.2335-2337.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  Identification of Enterococcus species isolated from human infections by a conventional test scheme.

Authors:  R R Facklam; M D Collins
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

2.  Use of penicillin-binding proteins for the identification of enterococci.

Authors:  R Williamson; L Gutmann; T Horaud; F Delbos; J F Acar
Journal:  J Gen Microbiol       Date:  1986-07

3.  Problems with the disk diffusion test for detection of vancomycin resistance in enterococci.

Authors:  J M Swenson; B C Hill; C Thornsberry
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

4.  Taxonomic studies on some group D streptococci.

Authors:  J A Farrow; D Jones; B A Phillips; M D Collins
Journal:  J Gen Microbiol       Date:  1983-05

Review 5.  Resistance to vancomycin and teicoplanin: an emerging clinical problem.

Authors:  A P Johnson; A H Uttley; N Woodford; R C George
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

6.  Self-transferable plasmids determining the hemolysin and bacteriocin of Streptococcus faecalis var. zymogenes.

Authors:  A E Jacob; G J Douglas; S J Hobbs
Journal:  J Bacteriol       Date:  1975-03       Impact factor: 3.490

7.  Recovery of resistant enterococci during vancomycin prophylaxis.

Authors:  A H Kaplan; P H Gilligan; R R Facklam
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

  7 in total
  43 in total

1.  Classification and identification of enterococci: a comparative phenotypic, genotypic, and vibrational spectroscopic study.

Authors:  C Kirschner; K Maquelin; P Pina; N A Ngo Thi; L P Choo-Smith; G D Sockalingum; C Sandt; D Ami; F Orsini; S M Doglia; P Allouch; M Mainfait; G J Puppels; D Naumann
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Enterococcus gallinarum endocarditis occurring on native heart valves.

Authors:  Sylvie Dargere; Michel Vergnaud; Renaud Verdon; Eric Saloux; Olivier Le Page; Roland Leclercq; Claude Bazin
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

3.  Evaluation of 15 motility media and a direct microscopic method for detection of motility in enterococci.

Authors:  Kenneth Van Horn; Clara Tóth; Reiko Kariyama; Ritsuko Mitsuhata; Hiromi Kumon
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

4.  Pretransplant Gut Colonization with Intrinsically Vancomycin-Resistant Enterococci (E. gallinarum and E. casseliflavus) and Outcomes of Allogeneic Hematopoietic Cell Transplantation.

Authors:  Armin Rashidi; Maryam Ebadi; Robin R Shields-Cutler; Todd E DeFor; Gabriel A Al-Ghalith; Patricia Ferrieri; Jo-Anne H Young; Gary M Dunny; Dan Knights; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2018-01-31       Impact factor: 5.742

5.  Clinical epidemiology of vancomycin-resistant Enterococcus gallinarum and Enterococcus casseliflavus bloodstream infections.

Authors:  Nicholas S Britt; Emily M Potter
Journal:  J Glob Antimicrob Resist       Date:  2015-12-21       Impact factor: 4.035

6.  Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.

Authors:  S Dutka-Malen; S Evers; P Courvalin
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

7.  Development of a DNA microarray for enterococcal species, virulence, and antibiotic resistance gene determinations among isolates from poultry.

Authors:  J Champagne; M S Diarra; H Rempel; E Topp; C W Greer; J Harel; L Masson
Journal:  Appl Environ Microbiol       Date:  2011-02-18       Impact factor: 4.792

8.  Analysis of peptidoglycan precursors in vancomycin-resistant Enterococcus gallinarum BM4174.

Authors:  P E Reynolds; H A Snaith; A J Maguire; S Dutka-Malen; P Courvalin
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

9.  Comparison of simple and rapid methods for identifying enterococci intrinsically resistant to vancomycin.

Authors:  K L Hanson; C P Cartwright
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  Use of tests for acidification of methyl-alpha-D-glucopyranoside and susceptibility to efrotomycin for differentiation of strains of Enterococcus and some related genera.

Authors:  M G Carvalho; L M Teixeira; R R Facklam
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.